Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

3.0K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.0K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

2.4K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.4K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

2.2K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

2.8K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.8K
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

583
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
583

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Challenges in IBD Research 2024: Pragmatic Clinical Research.

Inflammatory bowel diseases·2024
Same author

Challenges in IBD Research 2024: Novel Technologies.

Inflammatory bowel diseases·2024
Same author

Overview to Challenges in IBD 2024-2029.

Inflammatory bowel diseases·2024
Same author

Challenges in IBD Research 2024: Preclinical Human IBD Mechanisms.

Inflammatory bowel diseases·2024
Same author

Hot avulsion <i>versus</i> argon plasma coagulation for the management of the non-ensnarable polyp: A multicenter, randomized controlled trial.

JGH open : an open access journal of gastroenterology and hepatology·2024
Same author

P033 Moving the Needle on Speaker Diversity at AIBD.

The American journal of gastroenterology·2023
Same journal

HER2-mutated lung squamous cell carcinoma responding to trastuzumab deruxtecan followed by pyrotinib: a Case Report.

Frontiers in pharmacology·2026
Same journal

Awareness, attitudes, and self-reported clinical management of antimicrobial-associated neurocognitive adverse effects among healthcare providers in Saudi Arabia.

Frontiers in pharmacology·2026
Same journal

Low-dose dasatinib in second-line therapy or beyond for the treatment of chronic-phase chronic myeloid leukemia: a real-world cohort study.

Frontiers in pharmacology·2026
Same journal

Natural products reshape osteosarcoma cell fate: promoting cell death.

Frontiers in pharmacology·2026
Same journal

<i>Leonurus japonicus</i> Houtt. extract containing isoquercitrin reduces airway inflammation in mice with allergic asthma.

Frontiers in pharmacology·2026
Same journal

Enhancing diabetes treatment by targeted nucleic acid and drug delivery using cell-penetrating peptides, peptide nucleic acids, and receptor targeting.

Frontiers in pharmacology·2026
See all related articles

Related Experiment Video

Updated: Nov 1, 2025

Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

25.5K

Exosomes in Intestinal Inflammation.

Kanchana K Ayyar1, Alan C Moss1

  • 1Division of Gastroenterology, Department of Medicine, Boston Medical Center, Boston, MA, United States.

Frontiers in Pharmacology
|June 28, 2021
PubMed
Summary
This summary is machine-generated.

Exosomes, tiny vesicles found in bodily fluids, show unique profiles in Inflammatory Bowel Disease (IBD). This review explores their cargo, gut effects, and therapeutic potential for IBD.

Keywords:
IBDcolitisexosomesextracellular vesiclesinflammation

More Related Videos

Isolation and Profiling of MicroRNA-containing Exosomes from Human Bile
06:59

Isolation and Profiling of MicroRNA-containing Exosomes from Human Bile

Published on: June 13, 2016

10.5K
Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
09:11

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model

Published on: February 14, 2021

9.9K

Related Experiment Videos

Last Updated: Nov 1, 2025

Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

25.5K
Isolation and Profiling of MicroRNA-containing Exosomes from Human Bile
06:59

Isolation and Profiling of MicroRNA-containing Exosomes from Human Bile

Published on: June 13, 2016

10.5K
Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
09:11

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model

Published on: February 14, 2021

9.9K

Area of Science:

  • Biochemistry
  • Cell Biology
  • Immunology

Background:

  • Exosomes are nanoscale vesicles secreted by cells, present in various bodily fluids like blood and feces.
  • These vesicles carry diverse molecular cargo, including nucleic acids, proteins, and lipids.
  • Altered exosome profiles are observed in Inflammatory Bowel Disease (IBD) patients' blood and fecal samples.

Purpose of the Study:

  • To review exosome characteristics in humans and mammals.
  • To investigate the cargo and gut-specific effects of exosomes.
  • To explore the therapeutic applications of exosomes in Inflammatory Bowel Disease (IBD).

Main Methods:

  • Literature review of studies on exosomes in mammals.
  • Analysis of exosome cargo composition.
  • Examination of exosome-gut interactions.
  • Evaluation of exosome-based therapeutic strategies for IBD.

Main Results:

  • Exosomes exhibit distinct profiles in IBD.
  • Circulating exosomes can be surface-targeted for IBD therapies, such as monoclonal antibodies.
  • Exosomes play a role in modulating the gut environment.

Conclusions:

  • Exosomes represent a promising area for IBD diagnostics and therapeutics.
  • Further research into exosome cargo and function can advance IBD treatment strategies.
  • Targeting exosomes offers a novel approach to managing Inflammatory Bowel Disease.